These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
591 related items for PubMed ID: 18837728
1. Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis. Bongiorno MR, Pistone G, Doukaki S, Aricò M. Dermatol Ther; 2008 Oct; 21 Suppl 2():S15-20. PubMed ID: 18837728 [Abstract] [Full Text] [Related]
2. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics. Papoutsaki M, Chimenti MS, Costanzo A, Talamonti M, Zangrilli A, Giunta A, Bianchi L, Chimenti S. J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299 [Abstract] [Full Text] [Related]
3. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial. Gladman DD, Mease PJ, Ritchlin CT, Choy EH, Sharp JT, Ory PA, Perdok RJ, Sasso EH. Arthritis Rheum; 2007 Feb; 56(2):476-88. PubMed ID: 17265483 [Abstract] [Full Text] [Related]
4. Infliximab in psoriasis and psoriatic arthritis. Papoutsaki M, Osório F, Morais P, Torres T, Magina S, Chimenti S, Costanzo A. BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278 [Abstract] [Full Text] [Related]
5. Adalimumab for the treatment of severe psoriasis and psoriatic arthritis. Papoutsaki M, Costanzo A, Chimenti MS, Chimenti S. Expert Opin Biol Ther; 2008 Mar; 8(3):363-70. PubMed ID: 18294106 [Abstract] [Full Text] [Related]
6. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab. Chew AL, Bennett A, Smith CH, Barker J, Kirkham B. Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561 [Abstract] [Full Text] [Related]
10. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study. Esposito M, Giunta A, Mazzotta A, Zangrilli A, Babino G, Bavetta M, Perricone R, Chimenti S, Chimenti MS. Dermatology; 2012 Aug; 225(4):312-9. PubMed ID: 23295383 [Abstract] [Full Text] [Related]
11. Treatment of psoriasis with adalimumab. Pitarch G, Sanchez-Carazo JL, Mahiques L, Perez-Ferriols MA, Fortea JM. Clin Exp Dermatol; 2007 Jan; 32(1):18-22. PubMed ID: 17305904 [Abstract] [Full Text] [Related]
14. A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week). Nanke Y, Kobashigawa T, Sugimoto N, Yamanaka H, Kotake S. Immunol Med; 2019 Jun; 42(2):99-102. PubMed ID: 31446856 [Abstract] [Full Text] [Related]
15. A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis. Gordon KB, Duffin KC, Bissonnette R, Prinz JC, Wasfi Y, Li S, Shen YK, Szapary P, Randazzo B, Reich K. N Engl J Med; 2015 Jul 09; 373(2):136-44. PubMed ID: 26154787 [Abstract] [Full Text] [Related]
17. Efficacy of adalimumab in the treatment of psoriasis: a retrospective study of 15 patients in daily practice. Sola-Ortigosa J, Sánchez-Regaña M, Umbert-Millet P. J Dermatolog Treat; 2012 Jun 09; 23(3):203-7. PubMed ID: 21787203 [Abstract] [Full Text] [Related]